Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: CASI Pharmaceutics, Clover Biopharmaceuticals, Daiichi Sankyo, GC Biopharma, Rznomics, Samsung Bioepis, Sanyou Biopharmaceuticals, Sirius Therapeutic, Takeda Pharmaceutical.